ICMJE DISCLOSURE FORM
Date: 11/29/2023
Your Name: Janani Saadia
Manuscript Title: Safety and efficacy of biologic therapy in patients with rheumatoid arthritis and
spondyloarthritis: Analysis from a nationwide multicenter registry
Manuscript Number (if known): Click or tap here to enter text.
In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are related to the
content of your manuscript. “Related” means any relation with for-profit or not-for-profit third parties whose interests may be
affected by the content of the manuscript. Disclosure represents a commitment to transparency and does not necessarily
indicate a bias. If you are in doubt about whether to list a relationship/activity/interest, it is preferable that you do so.
The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains to the
epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive medication, even if
that medication is not mentioned in the manuscript.
In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items, the time
frame for disclosure is the past 36 months.
Name all entities with whom you have this Specifications/Comments (e.g., if payments were
relationship or indicate none (add rows as needed) made to you or to your institution)
Time frame: Since the initial planning of the work
1 All support for the
present ☒ None
manuscript (e.g.,
funding, provision
of study
materials, medical Click the tab key to add additional rows.
writing, article
processing
charges, etc.)
No time limit for
this item.
Time frame: past 36 months
2 Grants or
contracts from ☒ None
any entity (if not
indicated in item
#1 above).
3 Royalties or
licenses ☒ None
4 Consulting fees
☒ None
112/13/2021ICMJE Disclosure Form
5 Payment or
honoraria for ☒ None
lectures,
presentations,
speakers
bureaus,
manuscript
writing or
educational
events
6 Payment for
expert testimony ☒ None
7 Support for
attending ☒ None
meetings and/or
travel
8 Patents planned,
issued or ☒ None
pending
9 Participation on
a Data Safety ☒ None
Monitoring
Board or
Advisory Board
10 Leadership or
fiduciary role in ☒ None
other board,
society,
committee or
advocacy group,
paid or unpaid
11 Stock or stock
options ☒ None
12 Receipt of
equipment, ☒ None
materials, drugs,
medical writing,
gifts or other
services
212/13/2021ICMJE Disclosure Form
13 Other financial
or non-financial ☒ None
interests
Please place an “X” next to the following statement to indicate your agreement:
☒ I certify that I have answered every question and have not altered the wording of any of the questions on this form.
312/13/2021ICMJE Disclosure Form
